Clascoterone
Winlevi (clascoterone) is a small molecule pharmaceutical. Clascoterone was first approved as Winlevi on 2020-08-26. The pharmaceutical is active against androgen receptor. Winlevi's patents are valid until 2030-07-25 (FDA).
| Trade Name | Winlevi |
|---|---|
| Common Name | Clascoterone |
| Indication | |
| Drug Class | Antiandrogens |
